OBJECTIVE: To describe a new FHM kindred, and to analyse the functional consequences of the disease-associated ATP1A2 p.G301R mutation in human cellular models grown at 37°C. PATIENTS AND METHODS: Seven patients were clinically evaluated and gave informed consent for molecular analysis. Extra-pyramidal rigidity of the limbs was present in four subjects and in three of them tongue apraxia was also observed. ATP1A2 and CACNA1A were analysed by direct sequencing. Functional consequences of the mutation were investigated by cell viability assays, Western blots, and immunocytochemistry. Three-dimensional models of the human Na(+)/K(+)-ATPase α2 subunit were generated by homology modelling using SWISS-MODEL. FINDINGS: Analysis of ATP1A2 showed a heterozygous mutation, c.901G>A predicting the replacement of arginine for glycine at residue 301 (p.G301R). Functional analysis suggested that the mutation completely abolished Na(+)/K(+)-ATPase function. CONCLUSIONS: The phenotypic spectrum of our FHM2 family includes some peculiar features. Functional data confirm that Na(+)/K(+)-ATPase haploinsufficiency caused by the ATP1A2 p.G301R mutation is responsible for FHM in the described family.
OBJECTIVE: To describe a new FHM kindred, and to analyse the functional consequences of the disease-associated ATP1A2p.G301R mutation in human cellular models grown at 37°C. PATIENTS AND METHODS: Seven patients were clinically evaluated and gave informed consent for molecular analysis. Extra-pyramidal rigidity of the limbs was present in four subjects and in three of them tongue apraxia was also observed. ATP1A2 and CACNA1A were analysed by direct sequencing. Functional consequences of the mutation were investigated by cell viability assays, Western blots, and immunocytochemistry. Three-dimensional models of the human Na(+)/K(+)-ATPase α2 subunit were generated by homology modelling using SWISS-MODEL. FINDINGS: Analysis of ATP1A2 showed a heterozygous mutation, c.901G>A predicting the replacement of arginine for glycine at residue 301 (p.G301R). Functional analysis suggested that the mutation completely abolished Na(+)/K(+)-ATPase function. CONCLUSIONS: The phenotypic spectrum of our FHM2 family includes some peculiar features. Functional data confirm that Na(+)/K(+)-ATPase haploinsufficiency caused by the ATP1A2p.G301R mutation is responsible for FHM in the described family.
Authors: Christian Staehr; Lise Hangaard; Elena V Bouzinova; Sukhan Kim; Rajkumar Rajanathan; Peter Boegh Jessen; Nathan Luque; Zijian Xie; Karin Lykke-Hartmann; Shaun L Sandow; Christian Aalkjaer; Vladimir V Matchkov Journal: J Cereb Blood Flow Metab Date: 2018-03-07 Impact factor: 6.200
Authors: Shaunna L Clark; Renan P Souza; Daniel E Adkins; Karolina Aberg; József Bukszár; Joseph L McClay; Patrick F Sullivan; Edwin J C G van den Oord Journal: Pharmacogenet Genomics Date: 2013-02 Impact factor: 2.089
Authors: Karl P Schlingmann; Sascha Bandulik; Cherry Mammen; Maja Tarailo-Graovac; Rikke Holm; Matthias Baumann; Jens König; Jessica J Y Lee; Britt Drögemöller; Katrin Imminger; Bodo B Beck; Janine Altmüller; Holger Thiele; Siegfried Waldegger; William Van't Hoff; Robert Kleta; Richard Warth; Clara D M van Karnebeek; Bente Vilsen; Detlef Bockenhauer; Martin Konrad Journal: Am J Hum Genet Date: 2018-11-01 Impact factor: 11.025
Authors: Pernille Bøttger; Simon Glerup; Bodil Gesslein; Nina B Illarionova; Toke J Isaksen; Anders Heuck; Bettina H Clausen; Ernst-Martin Füchtbauer; Jan B Gramsbergen; Eli Gunnarson; Anita Aperia; Martin Lauritzen; Kate L Lambertsen; Poul Nissen; Karin Lykke-Hartmann Journal: Sci Rep Date: 2016-02-25 Impact factor: 4.379